ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer A Novel Two-Hit, Sparing-Material Approach

被引:111
作者
Pelosi, Giuseppe [1 ,3 ]
Fabbri, Alessandra [1 ]
Bianchi, Fabrizio [2 ,4 ]
Maisonneuve, Patrick [5 ]
Rossi, Giulio [6 ]
Barbareschi, Mattia [7 ]
Graziano, Paolo [8 ]
Cavazza, Alberto [9 ]
Rekhtman, Natasha [10 ]
Pastorino, Ugo [11 ]
Scanagatta, Paolo [11 ]
Papotti, Mauro [12 ,13 ]
机构
[1] Fdn IRCCS Natl Canc Inst, Dept Pathol & Lab Med, I-20133 Milan, Italy
[2] Fdn IRCCS Natl Canc Inst, Div Thorac Surg, I-20133 Milan, Italy
[3] Univ Milan, Sch Med, Dept Med Surg & Dent, Milan, Italy
[4] IFOM, Milan, Italy
[5] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy
[6] Azienda Osped Univ Policlin, Sect Pathol Anat, Modena, Italy
[7] Osped S Chiara, Div Pathol Anat, Trento, Italy
[8] Osped San Camillo Forlanini, Div Pathol Anat, Rome, Italy
[9] Osped S Maria Nuova, Div Pathol Anat, Reggio Emilia, Italy
[10] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[11] Fdn IRCCS Natl Canc Inst, Div Thorac Surg, I-20133 Milan, Italy
[12] San Luigi Hosp, Div Pathol Anat, Orbassano, Italy
[13] Univ Turin, Orbassano, Italy
关键词
NSCLC; Morphology; Biopsy; Cellblock; Surgical specimen; Immunohistochemistry; Diagnosis; TTF1; p40; p63; SQUAMOUS-CELL; TRIPARTITE DIFFERENTIATION; PULMONARY ADENOCARCINOMAS; PROGNOSTIC-SIGNIFICANCE; PATHOLOGICAL DIAGNOSIS; STEM-CELLS; CARCINOMA; P63; EXPRESSION; CLASSIFICATION;
D O I
10.1097/JTO.0b013e31823815d3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be demanding. As sparing material for molecular testing is mandatory, a minimalist immunohistochemistry (IHC)-based diagnostic approach is warranted by means of novel, reliable, and easy-to-assess biomarkers. Methods: Forty-six consecutive biopsy/cellblock samples and the corresponding resection specimens (as the gold standard for morphology and IHC) from 30 adenocarcinomas (AD), 10 squamous carcinomas (SQC), 5 adenosquamous carcinomas (ADSQC), and 1 sarcomatoid carcinoma (SC) were IHC-evaluated for p40 [corresponding to nontransactivating Delta Np63 isoforms] and thyroid transcription factor-1 (TTF1) by semiquantitative assessment. For p40, also immunodecoration intensity was taken into account and dichotomized as strong or low. Results: Nonrandom and overlapping distributions of the relevant markers were found in biopsy/cellblock and surgical specimens, which closely correlated with each other and the diverse tumor categories, with no differences in area under curve-receiver-operating-characteristic curves for each marker between any two samples, including p40 and p63. Diagnostic combinations were p40-/TTF1+ or TTF1- for AD (where p40 was negative, apart from 5/30 AD showing at the best 1-2% tumor cells with low intensity); p40+/TTF1- (p40 strong and by far higher than 50%) for SQC; and p40+/TTF1+ or p40+/TTF1- (p40 strong and less than 50%) for ADSQC. The single SC case was p40-/TTF1-, suggesting glandular lineage. Practically, 41/46 (89%) tumors were correctly classified by IHC on small samples, including 30 AD, 10 SQC, 1/5 ADSQC, and no SC. Underdiagnosis of ADSQC was actually because of sampling error of biopsies/cellblocks rather than insufficient biomarker robustness, whereas underdiagnosis of SC was really because of the failure of either marker to highlight epithelial-mesenchymal transition. Conclusions: This minimalist IHC-based model of p40 and TTF1 on biopsy/cellblock samples was effective to correctly subtype most cases of lung cancer.
引用
收藏
页码:281 / 290
页数:10
相关论文
共 70 条
[1]  
[Anonymous], 2011, TNM CLASSIFICATION M
[2]  
[Anonymous], MOD PATHOL
[3]  
Bishop M.M., 1975, DISCRETE MULTIVARIAT
[4]  
Bishop P, IMMUNOHISTOCHEMICAL
[5]  
Cakir E, 2009, ACTA CHIR BELG, V109, P489
[6]   Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy [J].
Cooke, David T. ;
Nguyen, Danh V. ;
Yang, Ying ;
Chen, Steven L. ;
Yu, Cindy ;
Calhoun, Royce F. .
ANNALS OF THORACIC SURGERY, 2010, 90 (03) :943-948
[7]   If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung [J].
Downey, Paul ;
Cummins, Robert ;
Moran, Margaret ;
Gulmann, Christian .
APMIS, 2008, 116 (06) :526-529
[8]   Adenosquamous lung carcinomas: A histologic subtype with poor prognosis [J].
Filosso, Pier Luigi ;
Ruffini, Enrico ;
Asioli, Sofia ;
Giobbe, Roberto ;
Macri, Luigia ;
Bruna, Maria Cristina ;
Sandri, Alberto ;
Oliaro, Alberto .
LUNG CANCER, 2011, 74 (01) :25-29
[9]  
Folpe AL, 1999, MODERN PATHOL, V12, P5
[10]   AIS is an oncogene amplified in squamous cell carcinoma [J].
Hibi, K ;
Trink, B ;
Patturajan, M ;
Westra, WH ;
Caballero, OL ;
Hill, DE ;
Ratovitski, EA ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5462-5467